FundedIQ
Biotechnology

TELA Bio: Funding, Investors & Team (Sep 2026)

We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. Please see our social media community guidelines at http://bit.ly/1UVcx0L

telabio.com LinkedIn Malvern, United States 101-250 employees
Biotechnology Life Science Pharmaceutical
Total raised
$46.0M
Rounds
1
Latest
Undisclosed round
Oct 2024

TELA Bio has raised $46.0M across 1 funding round on record, the most recent an undisclosed round of $46.0M announced in Oct 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TELA Bio Company Profile and Key Stats

Total funding raised
$46.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$46.0M in Oct 2024
Employees
101-250
reported band
Headquarters
Malvern, United States

Latest funding round on record: Oct 2024.

TELA Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$46.0M

TELA Bio Founders and Leadership Team

Name
Role
Contact
Maarten Persenaire
Founder
Locked

Contact details for the TELA Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

TELA Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

TELA Bio's latest round of $46.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TELA Bio in Biotechnology and Malvern

Companies Similar to TELA Bio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

TELA Bio Funding FAQs

What does TELA Bio do?

We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. Please see our social media community guidelines at http://bit.ly/1UVcx0L

How much funding has TELA Bio raised?

TELA Bio has raised $46.0M across 1 round on record. The most recent is an undisclosed round of $46.0M announced in Oct 2024.

When did TELA Bio last raise funding?

TELA Bio's most recent funding round on record is an undisclosed round of $46.0M, announced in Oct 2024.

Who founded TELA Bio?

FundedIQ lists Maarten Persenaire (Founder) at TELA Bio.

Where is TELA Bio headquartered?

TELA Bio is based in Malvern, Pennsylvania, United States.

How many employees does TELA Bio have?

TELA Bio is in the 101-250 employee band.

How does TELA Bio's funding compare to other Biotechnology startups?

TELA Bio's latest round of $46.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's TELA Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TELA Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.